Equity Analysis

Company News

    Kalahridhaan Trendz Ltd
    Industry :  Textiles - Products
    BSE Code
    ISIN Demat
    Book Value()
    92283
    INE02M801018
    28.2870774
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    KTL
    4.31
    34.63
    EPS(TTM)
    Face Value()
    Div & Yield %:
    4.68
    10
    0
     
Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
Dec 16,2024
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solution, 10 mg/mL. Glenmark's Lacosamide Oral Solution, 10 mg/mL is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat®2 Oral Solution, 10 mg/mL of UCB, Inc.

According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat® Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million.